Bayer
Investing.com – European stock markets retreated Tuesday as investors digested fresh regional employment and inflation data as well as quarterly earnings from some major companies. At 07:35 ET (12:35 GMT), the in Germany traded 1% lower, the in France fell 1.3% and the in the U.K. dropped 1%. European equities…
By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) -Bayer’s earnings will likely slip further next year on weak agricultural markets, the company said on Tuesday, pummelling its shares and piling more pressure on its chief executive to deliver on turnaround efforts. CEO Bill Anderson has launched a push to cut…
By Brendan Pierson (Reuters) -Bayer must pay $78 million to a Pennsylvania man who said he got cancer from using the company’s Roundup weedkiller, a state court jury in Philadelphia found on Thursday. The verdict follows previous consecutive victories for Bayer (OTC:) in that court. The company had won 14…
Investing.com — BofA Securities in a note dated Friday upgraded Bayer’s (ETR:) rating to ‘neutral’ from ‘underperform’ reflecting a more favorable outlook on the company’s litigation challenges and overall business prospects. This upgrade is accompanied by an increase in the price objective to EUR 31 per share (ADR $8.55), up…
By Dietrich Knauth NEW YORK (Reuters) -A Pennsylvania judge on Tuesday slashed a $2.25 billion U.S. verdict against Bayer (OTC:) to $400 million for a Pennsylvania man who said he developed cancer from exposure to the company’s Roundup weedkiller. A jury in the Philadelphia Court of Common Pleas found that…
By Nate Raymond and Jonathan Stempel (Reuters) – A Missouri judge slashed a $1.56 billion verdict against Bayer (OTC:) to $611 million for three people who claimed its Roundup weed killer caused their cancer, by reducing punitive damages. Bayer said on Friday it is appealing. The German company’s Monsanto (NYSE:)…
